Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

Figure 1

Kaplan-Meier curves for BAP1 expression in patient cohort. Retained nuclear expression in surgical sections was associated with increased survival times (a). Median survival was 6 months () and 11 months () for negative and positive BAP1 expression, respectively (). BAP1 expression in cytology sections was not significantly associated with prognosis (b). Median survival was 8 months () and 9 months () for negative and positive BAP1 expression, respectively ().

(a)

(b)